解读miRNAs在阿尔茨海默病中的作用:预测向和途径调制 - - 一项系统性审查
Monika Sharma1, Pankaj Pal2, Sukesh Kumar Gupta3
1Department of Pharmacy, Banasthali Vidyapith, Rajasthan, India.
Ageing research reviews
|September 5, 2024
概括
微RNAs (miRNAs) 通过调节关键途径,在阿尔茨海默病 (AD) 病原发生过程中发挥关键作用. 了解这些小RNA为新型诊断生物标志物和AD治疗策略提供了潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 阿尔茨海默病 (AD) 是一种复杂的神经退行性疾病,受遗传和环境因素的影响.
- 微RNA (miRNA) 是小型非编码RNA,它们调节基因表达,并参与各种生物过程.
- 对miRNAs的失调越来越被认为是AD病变发生的一个重要因素.
研究的目的:
- 综合审查miRNAs在阿尔茨海默氏症病原发生中的作用.
- 阐明miRNAs影响AD特征的机制,如粉样β和病理.
- 探索miRNAs作为AD生物标志物和治疗点的潜力.
主要方法:
- 关于miRNA生物发生,功能及其在AD中的参与研究的文献综述.
- 在AD中分析miRNA表达模式及其功能后果.
- 检查用于miRNA目标预测的计算和实验方法.
- 对目前和新兴的基于miRNA的治疗策略进行审查.
主要成果:
- 在AD中,miRNAs显著失调,影响了粉样β代谢,高酸化,神经炎症,氧化应激和突触功能.
- 特定的miRNAs已被确定为AD病理途径的关键调节者.
- 计算和实验方法已经成功地确定了许多与AD相关的miRNA目标.
- miRNAs作为早期诊断的生物标志物和作为新型治疗干预措施的目标具有前景.
结论:
- 微RNA是阿尔茨海默氏症病原体的组成部分,影响多个关键途径.
- 针对miRNAs为开发AD的新型诊断和治疗策略提供了一个有希望的途径.
- 需要进一步的研究,以克服将基于miRNA的方法转化为临床实践的挑战.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170


